A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab

CNS involvement in sarcoidosis is seen in 5-10% of cases. Long term treatment involves steroids and other immunomodulatory agents, including infliximab. Chronic immunosuppression can result in increased patient susceptibility to opportunistic infections. We present a case of fatal aspergillosis in a patient with neurosarcoidosis treated with infliximab.A 55-year-old woman with neurosarcoidosis on infliximab (started 4 months prior) and...